Human umbilical cord–derived mesenchymal stem cells improve chronic pancreatitis in rats via the AKT-mTOR-S6K1 signaling pathway

References

• Singh VK, Yadav D, Garg PK. Diagnosis and management of chronic pancreatitis: a review. Jama. 2019;322(24):2422–2434.
   PubMed Web of Science ®Google Scholar
• Sun Z, Gou W, Kim DS, et al. Adipose stem cell therapy mitigates chronic pancreatitis via differentiation into acinar-like cells in mice. Mol Ther. 2017;25(11):2490–2501.
   PubMed Web of Science ®Google Scholar
• Bansod S, Doijad N, Godugu C. Berberine attenuates severity of chronic pancreatitis and fibrosis via AMPK-mediated inhibition of TGF-β1/Smad signaling and M2 polarization. Toxicol Appl Pharmacol. 2020;403:115162.
   PubMed Web of Science ®Google Scholar
• Xue R, Wang J, Yang L, et al. Coenzyme Q10 ameliorates pancreatic fibrosis via the ROS-triggered mTOR signaling pathway. Oxid Med Cell Longev. 2019;2019:8039694.
   PubMed Web of Science ®Google Scholar
• Xu C, Shen J, Zhang J, et al. Recombinant interleukin-1 receptor antagonist attenuates the severity of chronic pancreatitis induced by TNBS in rats. Biochem Pharmacol. 2015;93(4):449–460.
   PubMed Web of Science ®Google Scholar
• Kichler A, Jang S. Chronic pancreatitis: epidemiology, diagnosis, and management updates. Drugs. 2020;80(12):1155–1168.
   PubMed Web of Science ®Google Scholar
• Ben Nasr M, Frumento D, Fiorina P. Adipose stem cell therapy for chronic pancreatitis. Mol Ther. 2017;25(11):2438–2439.
   PubMed Web of Science ®Google Scholar
• Li XC, Lu XL, Chen HH. α-Tocopherol treatment ameliorates chronic pancreatitis in an experimental rat model induced by trinitrobenzene sulfonic acid. Pancreatology. 2011;11(1):5–11.
   PubMed Web of Science ®Google Scholar
• Cui LH, Li CX, Zhuo YZ, et al. Saikosaponin d ameliorates pancreatic fibrosis by inhibiting autophagy of pancreatic stellate cells via PI3K/Akt/mTOR pathway. Chem Biol Interact. 2019;300:18–26.
   PubMed Web of Science ®Google Scholar
• Kawakubo K, Ohnishi S, Fujita H, et al. Effect of fetal membrane-derived mesenchymal stem cell transplantation in rats with acute and chronic pancreatitis. Pancreas. 2016;45(5):707–713.
   PubMed Web of Science ®Google Scholar
• Niina Y, Ito T, Oono T, et al. A sustained prostacyclin analog, ONO-1301, attenuates pancreatic fibrosis in experimental chronic pancreatitis induced by dibutyltin dichloride in rats. Pancreatology. 2014;14(3):201–210.
   PubMed Web of Science ®Google Scholar
• Zhou CH, Lin L, Zhu XY, et al. Protective effects of edaravone on experimental chronic pancreatitis induced by dibutyltin dichloride in rats. Pancreatology. 2013;13(2):125–132.
   PubMed Web of Science ®Google Scholar
• Jung KH, Song SU, Yi T, et al. Human bone marrow-derived clonal mesenchymal stem cells inhibit inflammation and reduce acute pancreatitis in rats. Gastroenterology. 2011;140(3):998–1008.
   PubMed Web of Science ®Google Scholar
• Yang B, Bai B, Liu CX, et al. Effect of umbilical cord mesenchymal stem cells on treatment of severe acute pancreatitis in rats. Cytotherapy. 2013;15(2):154–162.
   PubMed Web of Science ®Google Scholar
• Haniffa MA, Collin MP, Buckley CD, et al. Mesenchymal stem cells: the fibroblasts’ new clothes? Haematologica. 2009;94(2):258–263.
   PubMed Web of Science ®Google Scholar
• Momeni A, Neelamegham S, Parashurama N. Current challenges for the targeted delivery and molecular imaging of stem cells in animal models. Bioengineered. 2017;8(4):316–324.
   PubMed Web of Science ®Google Scholar
• Liu B, Ding F, Hu D, et al. Correction to: human umbilical cord mesenchymal stem cell conditioned medium attenuates renal fibrosis by reducing inflammation and epithelial-to-mesenchymal transition via the TLR4/NF-κB signaling pathway in vivo and in vitro. Stem Cell Res Ther. 2018;9(1):76.
   PubMedGoogle Scholar
• Dc D, Yh C, Wc S, et al. Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy. Cell Transplant. 2015;24(3):339–347.
   PubMed Web of Science ®Google Scholar
• Kawakubo K, Ohnishi S, Kuwatani M, et al. Mesenchymal stem cell therapy for acute and chronic pancreatitis. J Gastroenterol. 2018;53(1):1–5.
   PubMed Web of Science ®Google Scholar
• Kim JY, Jeon HB, Yang YS, et al. Application of human umbilical cord blood-derived mesenchymal stem cells in disease models. World J Stem Cells. 2010;2(2):34–38.
   PubMedGoogle Scholar
• Um SH, Sticker-Jantscheff M, Chau GC, et al. S6K1 controls pancreatic β cell size independently of intrauterine growth restriction. J Clin Invest. 2015;125(7):2736–2747.
   PubMed Web of Science ®Google Scholar
• Aslan JE, Tormoen GW, Loren CP, et al. S6K1 and mTOR regulate Rac1-driven platelet activation and aggregation. Blood. 2011;118(11):3129–3136.
   PubMed Web of Science ®Google Scholar
• Du HY, Wang R, Li JL, et al. Ligustrazine induces viability, suppresses apoptosis and autophagy of retinal ganglion cells with ischemia/reperfusion injury through the PI3K/Akt/mTOR signaling pathway. Bioengineered. 2021;12(1):507–515.
   PubMed Web of Science ®Google Scholar
• An W, Zhu JW, Jiang F, et al. Fibromodulin is upregulated by oxidative stress through the MAPK/AP-1 pathway to promote pancreatic stellate cell activation. Pancreatology. 2020;20(2):278–287.
   PubMed Web of Science ®Google Scholar
• Manohar M, Kandikattu HK, Verma AK, et al. IL-15 regulates fibrosis and inflammation in a mouse model of chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2018;315(6):G954–g965.
   PubMed Web of Science ®Google Scholar
• Vojdani Z, Bagheri J, Talaei-Khozani T, et al. Fetal microchimerism in mouse caerulein-induced pancreatitis model. Iran J Basic Med Sci. 2018;21(9):889–895.
   PubMed Web of Science ®Google Scholar
• Chen L, Chen Y, Yun H, et al. Tetramethylpyrazine (TMP) protects rats against acute pancreatitis through NF-κB pathway. Bioengineered. 2019;10(1):172–181.
   PubMed Web of Science ®Google Scholar
• Ishiwatari H, Sato Y, Murase K, et al. Treatment of pancreatic fibrosis with siRNA against a collagen-specific chaperone in vitamin A-coupled liposomes. Gut. 2013;62(9):1328–1339.
   PubMed Web of Science ®Google Scholar
• Bynigeri RR, Jakkampudi A, Jangala R, et al. Pancreatic stellate cell: pandora’s box for pancreatic disease biology. World J Gastroenterol. 2017;23(3):382–405.
   PubMed Web of Science ®Google Scholar
• Griggs LA, Hassan NT, Malik RS, et al. Fibronectin fibrils regulate TGF-β1-induced epithelial-mesenchymal transition. Matrix Biol. 2017;60-61:157–175.
   PubMed Web of Science ®Google Scholar
• Hull RL, Bogdani M, Nagy N, et al. Hyaluronan: a mediator of islet dysfunction and destruction in diabetes? J Histochem Cytochem. 2015;63(8):592–603.
   PubMed Web of Science ®Google Scholar
• Wang CH, Gao ZQ, Ye B, et al. Effect of emodin on pancreatic fibrosis in rats. World J Gastroenterol. 2007;13(3):378–382.
   PubMed Web of Science ®Google Scholar
• Liu Z, Gan L, Liu G, et al. Sirt1 decreased adipose inflammation by interacting with Akt2 and inhibiting mTOR/S6K1 pathway in mice. J Lipid Res. 2016;57(8):1373–1381.
   PubMed Web of Science ®Google Scholar
• Wang Y, Ding Q, Cj Y, et al. The crosstalk of mTOR/S6K1 and Hedgehog pathways. Cancer Cell. 2012;21(3):374–387.
   PubMed Web of Science ®Google Scholar
• De Jong B, Barros ER, Hoenderop JGJ, et al. Recent advances in extracellular vesicles as drug delivery systems and their potential in precision medicine. Pharmaceutics. 2020;12(11):1006.
   Web of Science ®Google Scholar
• Hirota M, Shimosegawa T, Kitamura K, et al. Continuous regional arterial infusion versus intravenous administration of the protease inhibitor nafamostat mesilate for predicted severe acute pancreatitis: a multicenter, randomized, open-label, phase 2 trial. J Gastroenterol. 2020;55(3):342–352.
   PubMed Web of Science ®Google Scholar
• Xu X, Yu H, Sun L, et al. Adipose‑derived mesenchymal stem cells ameliorate dibutyltin dichloride‑induced chronic pancreatitis by inhibiting the PI3K/AKT/mTOR signaling pathway. Mol Med Rep. 2020;21(4):1833–1840.
   PubMed Web of Science ®Google Scholar